Jin H Kim

Manager, Business Development at Piramal Pharma Solutions

Jin H Kim currently serves as the Manager of Business Development at Piramal Pharma Solutions, focusing on customer relationship development and account growth in the Bay Area and Pacific Northwest for Small Molecule API and Drug Product offerings. Previously, Jin held the position of Associate Director of Business Development at CoreRx, Inc., facilitating drug development processes for pharmaceutical and biotechnology companies. Prior experience includes roles as Sales Account Manager and Sales Associate at Univar, as well as a Sales Consultant - Systems Analyst II at Sanofi, where compliance monitoring was a key responsibility. Jin's experience also encompasses consulting roles at Covex LLC and Johnson & Johnson, with significant contributions to laboratory information management systems. Educational background includes a Bachelor of Science in Chemistry and Biochemistry from Villanova University.

Location

San Francisco, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Piramal Pharma Solutions

3 followers

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.